Daniel C. Rowe
Impact in
- Immunology top 0.5%
- Immune Response and Inflammation
- interferon and immune responses
- Immune Cell Function and Interaction
- Clinical Biochemistry top 0.5%
- Advanced Glycation End Products research
Papers in
-
- Immune Response and Inflammation 7
- interferon and immune responses 3
-
- S100 Proteins and Annexins 2
- Protein Kinase Regulation and GTPase Signaling 2
- Co-authors
- Douglas T. Golenbock (6 shared papers)Katherine A. Fitzgerald (6 shared papers)Anthony J. Coyle (2 shared papers)Eicke Latz (3 shared papers)Sarah M. McWhirter (2 shared papers)Tom Maniatis (2 shared papers)Sha-Mei Liao (1 shared paper)Ronald Herbst (3 shared papers)
- Journals
- Proceedings of the National Academy of Sciences (3 papers)Biochemical Society Transactions (1 paper)Cellular Microbiology (1 paper)The Journal of Experimental Medicine (1 paper)Nature Immunology (1 paper)
- Partner nations
- United StatesUnited KingdomIreland
In The Last Decade
Daniel C. Rowe
13 papers receiving 5.7k citations
Daniel C. Rowe's Hit Papers
Peers
Comparison fields: 5 of 113
- Immunology 4.0k
- Clinical Biochemistry 577
- Cancer Research 1.1k
- Infectious Diseases 501
- Microbiology 174
Countries citing papers authored by Daniel C. Rowe
This map shows the geographic impact of Daniel C. Rowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel C. Rowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel C. Rowe more than expected).
Fields of papers citing papers by Daniel C. Rowe
This network shows the impact of papers produced by Daniel C. Rowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel C. Rowe. The network helps show where Daniel C. Rowe may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel C. Rowe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | IKKε and TBK1 are essential components of the IRF3 signaling pathway Hit paper breakdown → | 2003 | 2266 |
| 2 | HMGB1 and RAGE in Inflammation and Cancer Hit paper breakdown → | 2010 | 1211 |
| 3 | LPS-TLR4 Signaling to IRF-3/7 and NF-κB Involves the Toll Adapters TRAM and TRIF Hit paper breakdown → | 2003 | 1008 |
| 4 | 2003 | 471 | |
| 5 | 2004 | 276 | |
| 6 | 2006 | 225 | |
| 7 | 2006 | 114 | |
| 8 | 2015 | 98 | |
| 9 | 2006 | 42 | |
| 10 | 2005 | 20 | |
| 11 | 2013 | 19 | |
| 12 | Periodic Reporting in a Continuous World: The Correlating Evolution of Technology and Financial Reporting | 2015 | 2 |
| 13 | 2000 | 1 |
About Daniel C. Rowe
Daniel C. Rowe is a scholar working on Immunology, Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine, having authored 13 papers that have together received 5.8k indexed citations. Recurring topics across this work include Immune Response and Inflammation (7 papers), NF-κB Signaling Pathways (5 papers), interferon and immune responses (3 papers), S100 Proteins and Annexins (2 papers), Neonatal Respiratory Health Research (2 papers), Protein Kinase Regulation and GTPase Signaling (2 papers), Respiratory Support and Mechanisms (1 paper) and Securities Regulation and Market Practices (1 paper). The work is most often cited by research in Immunology (4.0k citations), Clinical Biochemistry (577 citations), Cancer Research (1.1k citations), Infectious Diseases (501 citations) and Microbiology (174 citations). Daniel C. Rowe has collaborated with scholars based in United States, United Kingdom and Ireland. Frequent co-authors include Douglas T. Golenbock, Katherine A. Fitzgerald, Anthony J. Coyle, Eicke Latz, Sarah M. McWhirter, Tom Maniatis, Sha-Mei Liao, Ronald Herbst, Gary P. Sims and Svend T. Rietdijk. Their work appears in journals such as Proceedings of the National Academy of Sciences, Biochemical Society Transactions, Cellular Microbiology, The Journal of Experimental Medicine and Nature Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.